TD Cowen Maintains Buy on Aurinia Pharmaceuticals, Raises Price Target to $18

Benzinga · 1d ago
TD Cowen analyst Stacy Ku maintains Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Buy and raises the price target from $17 to $18.